Our findings show that Amlexanox caused an upregulation in GRK5 expression in an MI mouse model and consequently upregulated MEF2α expression, suggesting that upregulating GRK5/MEF2α has a possible role in the downregulation of NF-κB-mediated inflammation. This evidence concerns the gene MEF2A and myocardial infarction.